Literature DB >> 2503503

Kinetic study of internalization and degradation of 131I-labeled follicle-stimulating hormone in mouse Sertoli cells and its relevance to other systems.

A Shimizu1, S Kawashima.   

Abstract

The behavior of 131I-labeled follicle-stimulating hormone (FSH) after binding to cell-surface receptors in cultured Sertoli cells of C57BL/6NCrj mice was investigated. Sertoli cells cultured in F12/DME were pulse-labeled with 131I-FSH for 10 min at 4 degrees C, followed by cold chase for various periods of time. After the cold chase Sertoli cells were treated with 0.2 M acetate (pH 2.5) to dissociate membrane-bound 131I-FSH (surface radioactivity). The medium containing radioactivity after cold chase was mixed with 20% trichloroacetic acid, centrifuged, and the radioactivity of the supernatant was measured (degraded hormone). The radiolabeled materials associated with each process (surface binding, internalization, and degradation) were concentrated with ultrafiltration and characterized with gel filtration and/or thin layer chromatography. The effects of lysosomotropic agents, NH4Cl and chloroquine, were studied. The cold chase study at 32 degrees C showed that the surface radioactivity was the largest among the three kinds of radioactivities associated with each process immediately after pulse labeling, but the surface radioactivity rapidly decreased, while the internalized radioactivity increased. The cold chase study at 4 degrees C did not show such time-related changes in radioactivities, and a high level of surface radioactivity constantly persisted. The surface and internalized radioactivities were due to 131I-FSH, and the degraded radioactivity was mainly due to [131I]monoiodotyrosine. When Sertoli cells were cultured with lysosomotropic agents, the internalized radioactivity increased, while the degraded radioactivity decreased. Based on these observations, a kinetic model was proposed and the relationships among the surface, internalized, and degraded radioactivities and cold chase time were calculated algebraically. The rate constants of dissociation, internalization, and degradation were calculated to be 8.28 x 10(-4), 4.30 x 10(-2), and 6.46 x 10(-3) min-1, respectively. The simulated theoretical values of surface, internalized, and degraded radioactivities were almost the same as our experimental data. The present results indicate that 131I-FSH bound to the cell-surface receptors internalizes into Sertoli cells and that the degraded products are instantaneously released from the cells as [131I]monoiodotyrosine. The intracellular processes may be subdivided into 1) translocation, 2) net degradation of internalized hormone in the lysosomes, and 3) release of degraded hormone mainly as [131I]monoiodotyrosine. The rate-limiting step of these serial reactions was in the degradation of 131I-FSH, which consisted of a few substeps.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503503

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Decreased degradation of internalized follicle-stimulating hormone caused by mutation of aspartic acid 6.30(550) in a protein kinase-CK2 consensus sequence in the third intracellular loop of human follicle-stimulating hormone receptor.

Authors:  Kerri S Kluetzman; Richard M Thomas; Cheryl A Nechamen; James A Dias
Journal:  Biol Reprod       Date:  2011-01-26       Impact factor: 4.285

2.  Follicle-stimulating hormone (FSH) induced internalization of porcine FSH receptor in cultured porcine granulosa cells and Chinese hamster ovary cells transfected with recombinant porcine FSH receptor cDNA.

Authors:  C Zhu; H Tian; Z Xiong; H Xia
Journal:  J Tongji Med Univ       Date:  2001

3.  Localization of follicle-stimulating hormone (FSH) immunoreactivity and hormone receptor mRNA in testicular tissue of infertile men.

Authors:  T M Böckers; E Nieschlag; M R Kreutz; M Bergmann
Journal:  Cell Tissue Res       Date:  1994-12       Impact factor: 5.249

4.  A chelating derivative of alpha-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma.

Authors:  D R Bard; C G Knight; D P Page-Thomas
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

Review 5.  The role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systems.

Authors:  Nahor Haddish-Berhane; Jenna L Rickus; Kamyar Haghighi
Journal:  Int J Nanomedicine       Date:  2007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.